Major depression and activation of the inflammatory response system

Advances in Experimental Medicine and Biology

Volumn 461, Issue , 1999, Pages 25-46

  Maes, M ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CYTOKINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; IRON; LIPID; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRACE ELEMENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUTE PHASE RESPONSE; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CYTOKINE RELEASE; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; INFLAMMATION; IRON METABOLISM; LIPID BLOOD LEVEL; NEUROENDOCRINE DISEASE; NONHUMAN; PRIORITY JOURNAL; STRESS; THYROID GLAND; TRACE METAL BLOOD LEVEL;

EID: 0033282727     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-585-37970-8_2     Document Type: Conference Paper

References (173)

1. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression
2. Sex hormones, immune responses, and autoimmune diseases
3. Differential effects of interleukin (IL)-1beta, IL-2, and IL-6 on responding for rewarding lateral hypothalamic stimulation
4. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro
5. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo
6. Influence of low-estrogen-containing oral contraceptives on lipoprotein phospholipid composition and mononuclear cell membrane fluidity
7. Effects of zimeldine and its metabolites, clomipramine, imipramine, and maprotiline in experimental allergic neuritis in Lewis rats
8. Acute phase proteins in major depression
9. Corticotropin-releasing-factor-producing neurons in the rat activated by interleukin-1
10. Immune markers in fibromyalgia: Comparison with major depressed patients and normal volunteers
11. Inhibiting effects of serotonin and serotonin antagonists on the migration of mononuclear leucocytes
12. Iron in infection, immunity inflammation, and neoplasia
13. Depression, immunocompetence, and prostaglandins of the E series
14. Release of interleukin-6 from anterior pituitary cell aggregates: Developmental pattern and modulation by glucocorticoids and forskolin
15. Estradiol enhances leukocyte binding to tumor necrosis factor-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1
16. Effects of interferon-gamma, interleukin-1beta, and tumour necrosis factor-alfa on the serotonin metabolism in the nucleus raphe dorsalis of the rat
17. Depression, stress, and immunological activation: The role of cytokines in depressive disorders
18. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine, and immune parameters in the rat
19. Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin-1
20. Low zinc intake increases apparent oxidation of linoleic and alpha-linolenic acids in the pregnant rat
21. Cytokines and sickness behavior
22. Polymorphonuclear (PMN) elastase levels in depressive disorders
23. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ, and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation
24. Novel method for the measurement of cytokine production by one-stage procedure
25. Cytokine production and lymphocyte transformation during stress
26. Human recombinant interleukin-1β decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats
27. Urinary excretion of biopterin and neopterin in psychiatric disorders
28. Effects of psychological stress on plasma interleukins-1 and beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortisol
29. Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia
30. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone
31. Virus infection as a stressor: Influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan
32. Kinetics of zinc metabolism in the rat: Effect of dibutyryl cAMP
33. Messengers and mediators: Interactions among lipids, eicosanoids, and cytokines
34. Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3-polyunsaturated fatty acids
35. Iron
36. Expression of a high-affinity serotonin transporter in human lymphocytes
37. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission
38. Effect of interleukin-1 (Il-1 on thyroid hormone metabolism in mice: Stimulation by Il-1 of iodothyronine 5′-deiodinating activity (type I) in the liver
39. Reduced binding of added zinc in serum of patients with decompensated hepatic cirrhosis
40. Hypocholesterolemia and affective disorders
41. Interleukin 1-induced depression of iron and zinc: Role of granulocytes and lactoferrin
42. Interactions between the gonadal steroids and the immune system
43. Recombinant leukocyte A interferon: Pharmacokinetics, single dose tolerance, and biologic effects in cancer patients
44. Inhibition of granulocyte function by steroids is not limited to corticoids. Studies with sex steroids
45. Depression and immunity: A meta-analytic review
46. Continuous infusion of interleukin-1β induces a nonthyroidal illness syndrome in the rat
47. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease
48. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy
49. A neuroimmunological model of schizophrenia and major depression: A review
50. Essential fatty acids, psychiatric disorders and neuropathies
51. Stimulation of the immune response during blockade of serotonin receptors by cyproheptadine
52. Specific uptake of serotonin by murine macrophages
53. The role of serotonin in the regulation of the immune response
54. Elevated levels of acute phase plasma proteins in major depression
55. Thyroid hormone metabolism in illness
56. Are CD4+ Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function
57. The adrenergic regulation of interleukin production by bone marrow cells during immobilization stress
58. Short-term immunological effects of induced emotion
59. Cytokines and acute phase proteins in major depression: Are there gender differences?
60. Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression
61. Effect of desipramine on immunological parameters in mice, and their reversal by stress
62. The phenomenon of the acute phase response
63. The anemia of chronic disease
64. The effects of psychological stress on plasma interleukin-6 activity in rats
65. Elevated levels of prostaglandin E2 and thromboxane B2 in depression
66. Brain neurotransmission during peripheral inflammation
67. CSF prostaglandin levels in depressed and schizophrenic patients
68. Altered zinc metabolism in mood disorder patients
69. Gender differences in IL-1α, IL-1β, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion
70. Low serum cholesterol is not associated with depression in the elderly: Data from an Australian community study
71. Zinc in depressive disorder
72. Acute phase protein alterations in major depression: A review
73. The Interleukin hypothesis of major depression
74. The immune pathophysiology of major depression
75. The serotonin hypothesis of major depression
76. Immune activation and major depression: A hypothesis
77. Editorial: Fatty acids, cytokines, and major depression
78. Depression-related disturbances in mitogen-induced lymphocyte responses, interleukin-1β, and soluble interleukin-2-receptor production
79. Antiphospholipid, anti-nuclear, Epstein-Barr, and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients
80. Anthropometric and biochemical assessment of the nutritional state in depression: Evidence for lower visceral protein plasma levels in depression
81. Evidence for a systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining
82. Disturbances in acute phase plasma proteins during melancholia: Additional evidence for the presence of an inflammatory process during that illness
83. Higher α1-antitrypsin, haptoglobin, ceruloplasmin, and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness
84. Interleukin-1β: A putative mediator of HPA-axis hyperactivity in major depression?
85. Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: Psychopathological correlates of hyperhaptoglobinemia during major depression
86. Relationships between interleukin-6 activity, acute phase proteins, and HPA-axis function in severe depression
87. Relationships between increased haptoglobin plasma levels and activity of cell-mediated immunity
88. Lower degree of esterification of serum cholesterol in depression: Relevance for depression and suicide research
89. Haptoglobin phenotypes and gene frequencies in unipolar major depression
90. Relationships between basal hypothalamic-pituitary-thyroid axis activity and plasma haptoglobin levels in depression
91. Hypozincaemia in depression
92. Increased neopterin and interferon gamma secretion and lower L-tryptophan levels in major depression; further evidence for immune activation in severe depression
93. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2, and transferrin receptor in major depression
94. Total serum protein and serum protein fractions in major depression
95. The monocyte-T lymphocyte hypothesis of major depression
96. Fatty acid composition in major depression: Decreased ω3 fractions in cholesteryl esters and increased C20:4ω6/C20:5ω3 ratio in cholesteryl esters and phospholipids
97. Alterations in iron metabolism and the erythron in major, depression: Further evidence for a chronic inflammatory process
98. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
99. The acute phase protein response in schizophrenia, mania, and major depression: Effects of psychotropic drugs
100. Lower high density lipoprotein cholesterol in major depression and in depressed men with serious suicidal attempts: Relationships to immune-inflammatory markers
101. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness
102. Serotonin-immune interactions in major depression: Lower serum tryptophan as a marker of an immune-inflammatory response
103. Negative immunoregulatory effects of antidepressants: Increased production of interleukin-10 and suppressed production of interferon-gamma
104. The effects of psychological stress on humans: Increased production of proinflammatory cytokines and a Th-1-like response in stress-induced anxiety
105. Influence of psychological stress on leukocyte subset distribution in normal humans: Evidence for interrelated immunosuppression and T cell activation
106. Immune and clinical correlates of psychological stress-induced production of interferon-γ and IL-10 in humans
107. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock
108. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition
109. Chronic restraint enhances interleukin-1-beta release in the basal state and after an endotoxin challenge, independently of adrenocorticotropin, and corticosterone release
110. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women
111. Acute phase proteins in affective disorders
112. Tricyclic antidepressants and immunity
113. 1996 Curt P. Richter Award. Effects of viral infection on corticosterone secretion and glucocorticoid receptor binding in immune tissues
114. Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus
115. Modification of cytokine secretion following mild emotional stimuli
116. Plasma cholesterol and depressive symptoms in older men
117. Brain regions involved in the development of acute phase responses accompanying fever in rabbits
118. Characteristics of fever and acute-phase responses induced in rabbits by IL-1 and TNF
119. Altered T-cell number and reduced suppressor cell activity in patients with affective psychosis
120. Investigations of the cellular immunity during depression and the free interval: Evidence for an immune activation in affective psychosis
121. Predictive clinical and laboratory parameters for serum zinc and copper in rheumatoid arthritis
122. Increased soluble interleukin-2 receptor concentrations in suicide attempters
123. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone 41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway
124. Influence of early life events on immune reactivity in adult mice
125. Exposure to acute stress induces brain interleukin-1beta protein in the rat
126. Nonthyroidal illness
127. Inhibiting effects of serotonin antagonists on the proliferation of mercuric chloride stimulated human peripheral blood T lymphocytes
128. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients
129. Psychoimmunoendocrine effects of panic disorder
130. Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently
131. Regulation of the human serotonin transporter by interleukin-1 beta
132. Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension
133. Reduced preference for sucrose in autoimmune mice: A possible role of interleukin-6
134. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
135. Cytokine production and serum proteins in depression
136. Major depressive disorder is associated with elevated monocyte counts
137. Increased CD56+ natural killer cells and related cytokines in major depression
138. Role of interleukin-1 in stress responses. A putative neurotransmitter
139. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat
140. The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat
141. Diets rich in lean beef increase arachidonic acid and long-chain ω3 polyunsaturated fatty acid levels in plasma phospholipids
142. Haptoglobin levels in a chronic mild stress model of depression in rats before and after treatment
143. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine
144. Indicators of immune activation in major depression
145. Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder
146. Serotonin, serotonergic agents, and their antagonists suppress humoral immune reaction in vitro
147. The macrophage theory of depression
148. Zinc and copper
149. An acute phase protein response in the olfactory, bulbectomized rat: Effect of sertraline treatment
150. Changes in immunoglobulin, complement, and acute phase protein levels in the depressed patients and normal controls
151. The inflammatory response system and the availability of tryptophan to the brain of patients with major depression and sleep disorders
152. Dietary supplementation with very long-chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases
153. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men
154. Trace element alterations in infectious diseases
155. Induction of interleukin-1 and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain
156. Albumin decrement in depression and cholesterol decrement in mania
157. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines
158. Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness
159. Mood and cognitive side effects of interferon-alpha therapy
160. Interleukin 1 (IL-1) type I receptors mediate activation of rat hypothalamus-pituitary-adrenal axis and interleukin 6 production as shown by receptor type selective deletion mutants of IL-1beta
161. Lower number of red blood cells, hematocrit, and hemoglobin in major depression: Effects of antidepressants
162. Lower total serum protein, albumin and beta- and gamma-globulin in major and treatment-resistant depression: Effects of antidepressant treatments
163. Fever and changes in plasma zinc and iron concentrations in the goat. The effects of interferon inducers and recombinant IFN-alpha 2a
164. Alterations in thyroid function in patients with systemic illnesses: The "euthyroid sick syndrome"
165. Sex differences in susceptibility to infections
166. Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness
167. Decreased locomotor activity produced by repeated, but not single, administration of murine-recombinant interferon-gamma in mice
168. Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1
169. Tricyclic antidepressants inhibit IL-6, IL-1β, and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells
170. Endotoxin produces a depressive-like episode in rats
171. Behavioral and psychological effects of immune activation: Implications for depression due to a general medical condition
172. Serotonin regulation of T cell subpopulations and of macrophage accessory function
173. Exposure to physical and psychological stressors elevates plasma interleukin 6: Relationship to the activation of hypothalamic-pituitary-adrenal axis